Retrospective review of the use of daptomycin for diabetic foot infections.
The increase in antibiotic resistance has led to a search for alternative treatments for diabetic foot infections. This retrospective review outlines the clinical outcomes reported for a lipopetide for these infections.
Cubist Pharmaceuticals, Lexington, Massachusetts, USA. karmon.johnson@cubist.com
K
K
Johnson
K C
KC
Lamp
L V
LV
Friedrich
D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017576:Daptomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D017719:Diabetic Foot / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing; D012189:Retrospective Studies; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D017576:Daptomycin